CSIMarket
 
Sientra Inc   (NASDAQ: SIEN)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 11
 Employees 242
 Revenues (TTM) (Millions $) 89
 Net Income (TTM) (Millions $) -59
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 3

Business Description


Sientra Inc is a medical technology company that specializes in the development and sale of breast implants and other aesthetic products used in plastic surgery. The company was founded in 2003 and is headquartered in Santa Barbara, California.

Sientra is one of the leading providers of breast implants in the United States and is focused on providing a range of products that meet the needs of both patients and surgeons. Their products are designed to be both safe and effective, incorporating the latest technological innovations and materials to enhance patient outcomes.

One of Sientra's key products is their line of silicone breast implants, which are made from a highly cohesive, form-stable silicone gel. This advanced gel material provides a more natural look and feel than traditional saline implants, and has a lower risk of rupturing or leaking over time. Sientra also offers a range of other breast implant options, including round and shaped implants, as well as implant systems designed for tissue expanders or reconstruction after breast cancer surgery.

In addition to breast implants, Sientra also offers a range of other aesthetic products, including facial implants, body contouring implants, and other surgical devices used in plastic and reconstructive surgery. The company's products are sold through a network of authorized distributors and directly to surgeons and medical professionals.

Sientra is committed to providing high-quality products and services to its customers, and emphasizes the importance of patient safety and satisfaction in all of its operations. The company's products are subject to rigorous testing and quality assurance processes to ensure that they meet the highest standards of safety and efficacy.

Overall, Sientra Inc is a well-respected and innovative medical technology company with a strong focus on improving patient outcomes and advancing the field of plastic and reconstructive surgery. Their state-of-the-art products and commitment to quality and safety make them a reliable choice for both patients and surgeons alike.


   Company Address: 3333 Michelson Drive Irvine 92612 CA
   Company Phone Number: 562-3500   Stock Exchange / Ticker: NASDAQ SIEN


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ANIK   -0.56%    
CUTR   -17.04%    
ESTA   -3.6%    
MDXG        4.15% 
SMTI        0.35% 
VERO   -10.25%    
• View Complete Report
   



Merger and Acquisition

Tiger Aesthetics Medical, LLC Wins Bid for Sientra's Breast Reconstruction Assets

Published Tue, Apr 2 2024 10:30 PM UTC


On date, Tiger Aesthetics Medical, LLC emerged as the successful bidder for certain assets used in Sientra s breast reconstruction and augmentation business. This development comes as part of Sientra Inc s Section 363 sales auction, where the company sought to sell off assets related to its breast implant business.
Sientra Inc is a company that operates in the medic...

Management Announcement

Sientra Pursues Strategic Sale Through Voluntary Chapter 11 Process to Address Financial Challenges and Maximize Stakeholder Value

Published Tue, Feb 13 2024 1:30 PM UTC


Sientra, a leading medical aesthetics company, has announced its intention to pursue a strategic sale of its business through a voluntary Chapter 11 process. This decision comes as the company seeks to address its financial challenges and ensure the long-term sustainability of its operations. In order to support ongoing operations during the sale process, Sientra has su...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.15
Working Capital Ratio 0.88
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -3.53 $
Revenues (TTM) 7.91 $
Cash Flow (TTM) -
Cash 1.33 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 368,880
Net Income per Employee (TTM) -244,310
Receivable Turnover Ratio (TTM) 2.67
Inventory Turnover Ratio (TTM) 1.27
Asset Turnover Ratio (TTM) 0.59

Profitability Ratios Current
Gross Margin (MRQ) 52.7 %
Operating Margin (MRQ) -49.38 %
Net Margin (MRQ) -77.63 %
Net Cash Flow Margin (MRQ) -18.98 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.